Kendall Capital Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Eyenukeyenuk.cominOct 2022 · $26M
Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs.
AI & Machine LearningDigital HealthHealthtechMedical DevicesWoodland Hills, US
Kaushal Solanki(Founder; Director, PhD)inGaurav Agarwal(Chief Executive Officer)in
BoardMads Dall(Director)Zina Affas Besse(Director)Marie-Louise Little(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.